WO2008085406A3 - Modified live (jmso strain) haemophilus parasuis vaccine - Google Patents
Modified live (jmso strain) haemophilus parasuis vaccine Download PDFInfo
- Publication number
- WO2008085406A3 WO2008085406A3 PCT/US2007/026153 US2007026153W WO2008085406A3 WO 2008085406 A3 WO2008085406 A3 WO 2008085406A3 US 2007026153 W US2007026153 W US 2007026153W WO 2008085406 A3 WO2008085406 A3 WO 2008085406A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell culture
- strain
- haemophilus parasuis
- jmso
- modified live
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/21—Haemophilus
Abstract
The present invention is a culture of cells of Haemophilus parasuis exhibiting attenuated pathogenicity and capable of triggering a protective immune response when administered to pigs as a live vaccine. The present invention is also a method of preparing the cell culture, a method of preparing a vaccine from the cell culture, and a live vaccine based on the cell culture. The cell culture was modified from a pathogenic parent strain by MNNG mutagenesis and was selected by complete dependence on streptomycin for growth.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/648,390 US8404253B2 (en) | 2006-12-28 | 2006-12-28 | Modified live (JMSO strain) Haemophilus parasuis vaccine |
US11/648,390 | 2006-12-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008085406A2 WO2008085406A2 (en) | 2008-07-17 |
WO2008085406A3 true WO2008085406A3 (en) | 2008-09-18 |
Family
ID=39493472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/026153 WO2008085406A2 (en) | 2006-12-28 | 2007-12-20 | Modified live (jmso strain) haemophilus parasuis vaccine |
Country Status (2)
Country | Link |
---|---|
US (1) | US8404253B2 (en) |
WO (1) | WO2008085406A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102559531B (en) * | 2010-12-15 | 2014-03-19 | 武汉科前动物生物制品有限责任公司 | Haemophilus parasuis 5 type high-density fermentation medium and application thereof |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8404253B2 (en) * | 2006-12-28 | 2013-03-26 | Newport Laboratories, Inc. | Modified live (JMSO strain) Haemophilus parasuis vaccine |
US9132183B2 (en) * | 2007-03-09 | 2015-09-15 | Newport Laboratories | Modified live (JMSO strain) Haemophilus parasuis vaccine |
EP2280725B1 (en) * | 2008-03-26 | 2012-05-23 | Intervet International B.V. | Vaccine for protection against haemophilus parasuis serotype 4 in piglets |
US8911743B2 (en) * | 2009-11-04 | 2014-12-16 | Regents Of The University Of Minnesota | Haemophilus parasuis polypeptides and methods of use |
US20130039941A1 (en) | 2010-04-23 | 2013-02-14 | Intervet International B.V. | Vaccine comprising inactivated cells of haemophilus parasuis bacteria of serotype 5 |
EP3052126A2 (en) * | 2013-10-04 | 2016-08-10 | Merial, Inc. | Haemophilus parasuis vaccine serovar type four |
JP6342011B2 (en) | 2014-04-01 | 2018-06-13 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | Prodrugs of HIV reverse transcriptase inhibitors |
CN106591189A (en) * | 2016-12-16 | 2017-04-26 | 青岛易邦生物工程有限公司 | Haemophilus parasuis strain |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2103355C1 (en) * | 1995-11-23 | 1998-01-27 | Государственное Федеральное предприятие Государственный научный центр прикладной микробиологии | Method of preparing attenuated immunogenic strains of pasteurella multocida |
WO2004064776A2 (en) * | 2003-01-14 | 2004-08-05 | Mississippi State University | Methods of preparation of live attenuated bacterial vaccines by alteration of dna adenine methylase (dam) activity in those bacteria |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6783764B1 (en) * | 1997-04-10 | 2004-08-31 | Akzo Nobel Nv | Actinobacillus pleuropneumoniae subunit vaccine |
US20020068068A1 (en) * | 1999-02-02 | 2002-06-06 | Mahan Michael J. | Method of creating antibodies and compositions used for same |
KR20070064666A (en) * | 2004-11-11 | 2007-06-21 | 화이자 프로덕츠 인코포레이티드 | Mutant porcine reproductive and respiratory syndrome virus |
ES2330904B1 (en) * | 2005-09-21 | 2010-09-23 | Fundacio Centre De Recerca En Sanitat Animal | HAEMOPHILUS PARASUIS POLINUCLEOTIDES AND ITS USE. |
PL2007419T3 (en) * | 2006-04-10 | 2012-09-28 | Intervet Int Bv | Vaccine against mycoplasma prrsv |
US8404253B2 (en) * | 2006-12-28 | 2013-03-26 | Newport Laboratories, Inc. | Modified live (JMSO strain) Haemophilus parasuis vaccine |
US8911743B2 (en) * | 2009-11-04 | 2014-12-16 | Regents Of The University Of Minnesota | Haemophilus parasuis polypeptides and methods of use |
-
2006
- 2006-12-28 US US11/648,390 patent/US8404253B2/en active Active
-
2007
- 2007-12-20 WO PCT/US2007/026153 patent/WO2008085406A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2103355C1 (en) * | 1995-11-23 | 1998-01-27 | Государственное Федеральное предприятие Государственный научный центр прикладной микробиологии | Method of preparing attenuated immunogenic strains of pasteurella multocida |
WO2004064776A2 (en) * | 2003-01-14 | 2004-08-05 | Mississippi State University | Methods of preparation of live attenuated bacterial vaccines by alteration of dna adenine methylase (dam) activity in those bacteria |
US20070082009A1 (en) * | 2003-01-14 | 2007-04-12 | Lawrence Mark L | Methods of preparation of live attenuated bacterial vaccine by alteration of dna adenine methylase (dam) activity in those bacteria |
Non-Patent Citations (9)
Title |
---|
BIGAS A ET AL: "Development of a genetic manipulation system for Haemophilus parasuis", VETERINARY MICROBIOLOGY, AMSTERDAM, NL, vol. 105, no. 3-4, 25 February 2005 (2005-02-25), pages 223 - 228, XP004740821, ISSN: 0378-1135 * |
BIGAS ANNA ET AL: "Colonization capacity and serum bactericidal activity of Haemophilus parasuis thy mutants", INTERNATIONAL MICROBIOLOGY, vol. 9, no. 4, December 2006 (2006-12-01), pages 297 - 301 URL, XP009101779, ISSN: 1139-6709 * |
DATABASE EMBL 16 April 2005 (2005-04-16), "Haemophilus parasuis ribosomal protein S12 (rps12) gene, complete cds", XP002484740, retrieved from EBI Database accession no. AY236072 * |
HOOKE A M ET AL: "Live attenuated bacterial vaccines: new approaches for safety and efficacy.", LANCET 29 JUN 1985, vol. 1, no. 8444, 29 June 1985 (1985-06-29), pages 1472 - 1474, XP002484737, ISSN: 0140-6736 * |
LINDE K ET AL: "STABLE LISTERIA MONOCYTOGENES LIVE VACCINE CANDIDATE STRAINS WITH GRADED ATTENUATION ON THE MOUSE MODEL", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 9, no. 2, 1 February 1991 (1991-02-01), pages 101 - 105, XP000175534, ISSN: 0264-410X * |
LINDE K: "[Use of attenuated mutants of Pasteurella multocida strain, pathogenic to calves, in experimental mouse model studies. 4. Immunogenicity of selected revertants of temperature-sensitive, streptomycin-dependent mutants as potential vaccine strains]", ARCHIV FÜR EXPERIMENTELLE VETERINÄRMEDIZIN 1978, vol. 32, no. 6, 1978, pages 943 - 949, XP009101801, ISSN: 0003-9055 * |
NIELSEN R: "Pathogenicity and immunity studies of Haemophilus parasuis serotypes", ACTA VETERINARIA SCANDINAVICA, vol. 34, no. 2, 1993, pages 193 - 198, XP009101790, ISSN: 0044-605X * |
OLIVEIRA SIMONE ET AL: "Haemophilus parasuis: New trends on diagnosis, epidemiology and control.", VETERINARY MICROBIOLOGY, vol. 99, no. 1, 26 March 2004 (2004-03-26), pages 1 - 12, XP002484736, ISSN: 0378-1135 * |
STUY J H ET AL: "Cloning, characterization, and DNA base sequence of the high-level streptomycin resistance gene strA1 of Haemophilus influenzae Rd.", JOURNAL OF BACTERIOLOGY SEP 1992, vol. 174, no. 17, September 1992 (1992-09-01), pages 5604 - 5608, XP002484739, ISSN: 0021-9193 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102559531B (en) * | 2010-12-15 | 2014-03-19 | 武汉科前动物生物制品有限责任公司 | Haemophilus parasuis 5 type high-density fermentation medium and application thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2008085406A2 (en) | 2008-07-17 |
US8404253B2 (en) | 2013-03-26 |
US20100255035A1 (en) | 2010-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008085406A3 (en) | Modified live (jmso strain) haemophilus parasuis vaccine | |
Yuan et al. | Identity, diversity, and molecular phylogeny of the endophytic mycobiota in the roots of rare wild rice (Oryza granulate) from a nature reserve in Yunnan, China | |
NZ595914A (en) | Vaccines comprising attenuated mycoplasma bovis strains and method for the attenuation | |
WO2010019262A3 (en) | Polyvalent vaccine | |
MX2011007551A (en) | Saccharomyces cerevisiae strains with phytosanitary capabilities. | |
DK2473189T3 (en) | Methods for reducing virucid activity in PCV-2 compositions and PCV-2 compositions with improved immunogenicity. | |
WO2010132112A3 (en) | Immunogenic compositions against tuberculosis | |
WO2013000717A3 (en) | Dermatologically effective yeast extract | |
NZ586238A (en) | Methods and compositions for immunizing pigs against porcine circovirus | |
WO2007024941A3 (en) | Polyvalent vaccine | |
WO2006127150A3 (en) | Dendritic cell compositions and methods | |
IN2014DN08830A (en) | ||
MY144689A (en) | Dengue serotype 1 attenuated strain | |
WO2007089677A3 (en) | Systems and methods for producing biofuels and related materials | |
NZ585777A (en) | Compositions and methods of enhancing immune responses to eimeria | |
WO2005089447A3 (en) | Streptococcus agalactiae vaccine | |
WO2009103960A3 (en) | Methods and compositions for modifying plant flavonoid composition and disease resistance | |
NZ603918A (en) | Improved methods for preparing squalene | |
WO2008012538A3 (en) | Live vaccine strains of francisella | |
CA2849393C (en) | Phytoseiid predatory mite releasing system and method for production. | |
UA98506C2 (en) | Attenuated mycoplasma gallisepticum strains | |
NZ589981A (en) | Cattle vaccines comprising a disrupted M. bovis bacterium | |
NO20060976L (en) | Vaccine | |
WO2011159092A3 (en) | Novel soil microorganism, novel oxidoreductase separated from the soil microorganism, gene encoding the oxidoreductase, and method for producing aglycones using the microorganism, the oxidoreductase and the gene | |
MX2016003676A (en) | Isolated bacterium of the genus streptomyces. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07863197 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07863197 Country of ref document: EP Kind code of ref document: A2 |